It has reached the top

Editorial Board Member

David Gewirtz
Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA, USA.
HomePage
Research Interests
autophagy, senescence, cancer chemotherapy, chemosensitization, radiosensitization, chemtoxicity.
Contributions:

An overview of resistance to Human epidermal growth factor receptor 2 (Her2) targeted therapies in breast cancer

Cancer Drug Resistance
ISSN 2578-532X (Online)
Follow Us

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/